About HBOHT

The effectiveness of oxygen therapy in the treatment of asthma has been confirmed by numerous studies. One of them is a report by a team of doctors from the University Center for Maritime and Tropical Medicine in Gdynia. It is a Polish center that started research on such use of oxygen therapy in the 1980s. In those years, chambers for HBOT were used. Patients were examined before the implementation of HBOT, and then after four sessions, after the end of therapy, and a month later. The results showed an improvement in their condition, and oxygen therapy was recommended for further research into the effects on asthma. Currently, modern, long term oxygen-hydrogen therapy in a comfortable hyperbaric chamber can significantly reduce asthma symptoms.

Alzheimer’s disease is a progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most people with the disease symptoms first, appear in their mid-60s and is the most common cause of dementia. Early-onset Alzheimer’s occurs between a person’s 30s and mid-60s but is very rare.
In a healthy organism, the brain uses about 20% oxygen, which allows only 10% of all neurons to act simultaneously. Regeneration of damaged neurons means additional oxygen demand, which the body easily absorbs thanks to the HBOHT. This causes the connections between neurons to be restored and inactive cells are stimulated.

COVID-19 can have prolonged effects on individuals, particularly older adults and those with underlying health conditions, but even young people can experience lingering symptoms for weeks or months after being infected. These persistent signs and symptoms may encompass various aspects, including lingering fatigue following physical or mental exertion, joint discomfort, chest pain, headaches or muscle pain, feelings of depression or anxiety, challenges with memory, concentration, or sleep, and a general lack of energy.
Although the majority of individuals with COVID-19 recover fully within a matter of weeks, a subset of people, including those who had mild cases of the virus, continue to grapple with these symptoms over an extended period. Furthermore, COVID-19 can impact our vital organs significantly, resulting in lung damage (particularly in the alveoli), brain-related issues (such as strokes), and heart damage (affecting the heart muscle).
In this context, Hyperbaric Oxygen-Hydrogen Therapy (HBOHT) emerges as a valuable and recommended aid for post-COVID-19 rehabilitation. Ongoing research in Europe, Russia, and Canada is demonstrating the positive effects of oxygen in this context. HBOHT stands as a natural approach that supports our body's intrinsic healing mechanisms, offering potential relief and recovery from the aftermath of the virus.

Depression is a mood and mental disorder that causes a persistent feeling of sadness and loss of interest. It can occur in varying degrees, affecting people of all ages. It affects how you feel, think, behave, and can lead to a variety of emotional and physical problems. It can be treated with medication, psychotherapy, and now HBOHT.
HBOHT allows for much greater oxygenation of the body and helps reduce anxiety and stress levels due to heightened oxygen flow within the brain creating a calming effect. Research suggests HBOHT can have a similar or equal therapeutic effect as psychotherapy when treating anxiety and depression.

For diabetics, issues such as cardiovascular disease, nerve damage, kidney damage, eye damage, extremity damage, Alzheimer’s disease, and depression can result from their condition. Increasing risk of death and lowing overall quality of life. In the context of these problems, HBOHT can bring perceptible relief to these symptoms and complications.
Numerous studies show that pressurized oxygen therapy can restore blood flow to the extremities allowing for improved circulation and reduction of gangrene. The latest research shows that regular use of oxygen therapy by patients with diabetes reduces the risk of foot amputation by as much as 33%.

The immune system protects our body from outside invaders: bacteria, viruses, fungi, and toxins. It is made up of different organs, cells, and proteins that work together. Low oxygen levels in the tissues (hypoxia) can suppress some aspects of the immune response, such as the cells’ ability to fight infection.
One of the effects of a reduced immunity response is the reduction of tissue oxygen demand. In this condition anaerobic bacteria (bacteria not requiring oxygen to grow) play an important role in the development of many systemic diseases. The reversal of this process is an adequate supply of oxygen to the cell. HBOHT can help the body’s immune response by oxygenating every cell and tissue.

A migraine headache is caused by changes in your nervous system and may progress through four stages: prodrome, aura, attack, and postdrome. 40-60% of people with migraines experience a prodrome phase. This may include constipation, depression, diarrhea, drowsiness, food cravings, or hyperactivity and irritability. Alternatively, you might not notice any symptoms. About 20% of people with migraines experience a more distinct migraine warning sign in a second phase, called the migraine aura.
Migraine aura is a set of neurological symptoms such as visual disturbances, hallucinations (dark spots, geometrical shapes, flashes of light), and even temporary blindness that precede the migraine pain. About 1% of aura cases resemble a stroke. People may experience temporary numbness in the arms and legs, sensory disturbance on one side of the body, and speech disorder. In the brains of people with a history of migraines, structural changes occurred more often than in people without. This includes irregularities in white matter and minor damage associated with hypoxia of the nerve tissue (similar to stroke). This was especially true for people who suffered from migraines with aura. White matter abnormalities were more frequent by up to 68% and damage related to hypoxia by 44%. HBOHT effectively oxygenates the brain, which translates directly into the reduction of discomfort and migraine symptoms.

Psoriasis is one of the most common skin diseases that have varying degrees of severity. However, when it takes the form of psoriatic arthritis, severity is increased with pain and inflammation of the joints. The enhanced oxygenation effect during Hyperbaric therapy can reduce inflammation and help alleviate symptoms. HBOHT has a similar effect in people struggling with rosacea, erythema, eczema, urticaria, and certain rashes.

Oxygen therapy is a widely recognized method of alleviating the symptoms of radiation reactions, and in 2004 it received an official recommendation of the European Committee for Hyperbaric Medicine. Patients undergo therapy in a pressure room with 150.0 kPa and a properly composed oxygen mixture. Such conditions allow to supply the cells with as much oxygen as possible, which has a positive effect on their regeneration after diseases and operations, extends the life span and accelerates the development of new blood vessels. Oxygen-Hydrogen therapy in a hyperbaric chamber may be very helpful in alleviating the effects of radiation therapy and radiation reactions. A series of treatments in the pressure chamber can have a positive effect on reducing inflammation, increasing oxygenation of tissues & improving blood circulation, strengthening the immune system, acceleration of tissue regeneration, and reducing the visibility of scars. Research confirms that oxygen therapy additionally helps to alleviate, among others, inflammation of the bladder, large intestine, ulcers, as well as damage to the skin and mucosa of the mouth.

A stroke occurs when the blood supply to part of your brain is interrupted or reduced, preventing brain tissue from getting oxygen and nutrients. Brain cells begin to die resulting in brain damage (necrosis). However, if you look at the tissues and neurons surrounding the necrosis, you will find that they still retain metabolic function. These neurons can be restored to normal or near-normal function with the oxygen-enriched environments provided by HBOHT and HBOT.
Research conducted by Dr. Shai Efrati indicates the high effectiveness of HBOT in improving neurological and physical functions in people after a stroke. Examining 162 patients who have had strokes in the past, Dr. Efrati treated them with 8 weeks of HBOT. After the 8 weeks of treatment, HBOT induced a significant increase in all cognitive function domains. Allowing 86% of patients to achieve Composite Spasticity Index (CSI).